UCSF and UCLA join national collaboration for cancer research
Renowned UC San Francisco immunologist Jeffrey Bluestone, Ph.D., has been named president and CEO of the Parker Institute for Cancer Immunotherapy, a national initiative launched with a $250 million grant from The Parker Foundation, a private philanthropic organization established by Silicon Valley entrepreneur Sean Parker.
Bluestone, who was named this month to a Blue Ribbon Panel that will help to guide Vice President Joe Biden’s National Cancer Moonshot Initiative, remains A.W. and Mary Margaret Clausen Distinguished Professor at UCSF, and will continue to oversee an active research program at the university.
The Parker Institute includes six centers – UCSF, Memorial Sloan Kettering Cancer Center, Stanford Medicine, UCLA, the University of Pennsylvania and The University of Texas MD Anderson Cancer Center. UCLA’s effort will be led by Antoni Ribas, M.D., a professor of medicine and director of the tumor immunology program at the UCLA Jonsson Comprehensive Cancer Center.
The UCSF center will be directed by Lewis Lanier, Ph.D., the J. Michael Bishop, M.D., Distinguished Professor and chair of UCSF’s Department of Microbiology and Immunology, which is ranked #2 worldwide by U.S. News and World Report.
Read full article about UC involvement in cancer initiative.